The Regulation on Products Derived from Human Tissues and Cells and Centers Concerning These Products, published in the Official Gazette dated 4 September 2025 (No. 33007), marks a major regulatory shift in Türkiye’s healthcare and biotechnology compliance framework. This new regulation introduces comprehensive quality, safety, licensing, authorization, inspection, and data governance standards for tissue and cell centers, biobanks, and human application facilities. It also repeals previous fragmented legislation and establishes a unified regulatory regime governing the production, storage, distribution, export, and clinical use of human-origin biological products. In this article, we provide a structured legal analysis of the Regulation, explain the roles of competent authorities, outline the key compliance obligations for healthcare operators, and assess the operational and investment implications for institutions operating in the life sciences and medical sectors.

For the whole text take a look at our website 
https://www.pilc.law/regulation-on-products-derived-from-human-tissues-and-cells/


Comments

  1. a new era is staring in Turkey health care field. The new Regulation hopefully will fulfill the gaps for the lack of any regulation about medical laboratories

    ReplyDelete
    Replies
    1. a new term for Turkey healthcare sector about medical laboratories...

      Delete
  2. Such a comprehensive article ! Valuable work, thank you

    ReplyDelete

Post a Comment

Popular posts from this blog

Company Registration in Turkey

Anti Dumping

Overview of Competition Law Services by Pi Legal Consultancy